CTNNB1 and breast cancer: Furthermore, has-miR-940 was consistently down-regulated in breast cancer tissues57, it can play oncogenic role in gastric cancer58, activates the Wnt/beta-catenin signaling activation by targeting GSK3β and sFRP1 in pancreatic carcinoma59, and act as a diagnostic and prognostic tool for prostate cancer60.